SCHEMBL17670516

SCHEMBL17670516

CC(=O)NCCSOC(C)=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.58
ALDH1A1 P00352 1/20 0.56
KDM4E B2RXH2 2/20 0.44
MAPK1 P28482 1/20 0.44
HIF1A Q16665 1/20 0.44
MTNR1A P48039 6/20 0.43
MTNR1B P49286 6/20 0.43
KMT2A Q03164 1/20 0.39
PAOX Q6QHF9 3/20 0.38
ADRA1A P35348 1/20 0.36
ZDHHC7 Q9NXF8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HDAC3 O15379 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC7 Q8WUI4 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC10 Q969S8 1/20 0.34
HDAC11 Q96DB2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24299488 0.80
SCHEMBL13161354 0.77 TSHR (0.56) TSHRALDH1A1KDM4EMAPK1HIF1A
SCHEMBL917149 0.74 TSHR (0.71) TSHRALDH1A1KDM4EMAPK1HIF1A
SCHEMBL24244862 0.74 TSHR (1.00) TSHRALDH1A1KDM4EMAPK1HIF1A
SCHEMBL8580369 0.72
SCHEMBL423954 0.72
SCHEMBL1930349 0.70 TSHR (0.65) TSHRALDH1A1KDM4EMAPK1HIF1A
SCHEMBL24907147 0.70
SCHEMBL20756150 0.70
SCHEMBL4739477 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11369568-B2 Microparticles comprising a sulphur-containing compound NOVABIOTICS LIMITED (GB) 2022-06-28 US disclosed
US-20190175501-A1 MICROPARTICLES COMPRISING A SULPHUR-ONTAINING COMPOUND NOVABIOTICS LIMITED (GB) 2019-06-13 US disclosed
US-20170348253-A1 Treatment of Drug-Resistant Microbial Infections NOVABIOTICS LIMITED (GB) 2017-12-07 US disclosed
US-20160102052-A1 Use of Cysteamine in Treating Infections caused by Yeasts/Moulds NOVABIOTICS LIMITED (GB) 2016-04-14 US disclosed